Drug
Talazoparib Plus Enzalutamide
Talazoparib Plus Enzalutamide: highest development phase Phase 3, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| talazoparib plus enzalutamide NCT04821622 | Phase 3 | Prostate Cancer |
Latest
No recent events.
Follow Talazoparib Plus Enzalutamide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.